Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Abiogen Pharma S.p.A.
DescriptionCombination of glibenclamide (5mg) and metformin (500mg)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerNewBridge Pharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today